CSIMarket


Integra Lifesciences Holdings Corp  (IART)
Other Ticker:  
 

Integra Lifesciences Holdings Corp

IART's Fundamental analysis








Integra Lifesciences Holdings's sales fell by -3.14 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 1243

Medical Equipment & Supplies industry recorded growth of revenues by 6.28 %

Integra Lifesciences Holdings faced net loss in contrast to the net income a year ago in I. Quarter 2024

More on IART's Growth


Integra Lifesciences Holdings
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Company is currently trading with Price to Cash flow multiple of 8.58 in trailing twelve-month period.
Company
62.24
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.6.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.13.


More on IART's Valuation
 
 Total Debt (Millions $) 1,761
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 339,911
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.03
 Tangible Book Value (Per Share $) -5.98

Integra Lifesciences Holdings
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Company is currently trading with Price to Cash flow multiple of 8.58 in trailing twelve-month period.
Company
62.24
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.6.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.13.

Integra Lifesciences Holdings Price to Book Ratio is at 1.53 higher than Industry Avg. of -600.24, and higher than S&P 500 Avg. of 0.01

More on IART's Valuation

  Market Capitalization (Millions $) 2,442
  Shares Outstanding (Millions) 78
  Employees 4,500
  Revenues (TTM) (Millions $) 1,530
  Net Income (TTM) (Millions $) 40
  Cash Flow (TTM) (Millions $) 285
  Capital Exp. (TTM) (Millions $) -69
  Total Debt (Millions $) 1,761
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 339,911
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 6.03
  Tangible Book Value (Per Share $) -5.98

  Market Capitalization (Millions $) 2,442
  Shares Outstanding (Millions) 78
  Employees 4,500
  Revenues (TTM) (Millions $) 1,530
  Net Income (TTM) (Millions $) 40
  Cash Flow (TTM) (Millions $) 285
  Capital Exp. (TTM) (Millions $) -69


    IART's Profitability Comparisons
Integra Lifesciences Holdings faced margin deterioration, primarily through cost pressure. Operating Margin fell in I. Quarter 2024 to 1.07 % from 9.08 % in IV. Quarter.







  Ratio
   Capital Ratio (MRQ) 5.09
  Total Debt to Equity (MRQ) 1.1
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.4
  Inventory Turnover Ratio (TTM) 1.77



Integra Lifesciences Holdings faced margin deterioration, primarily through cost pressure. Operating Margin fell in I. Quarter 2024 to 1.07 % from 9.08 % in IV. Quarter.



More on IART's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com